# Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A

> **NCT00803816** · PHASE2 · COMPLETED · sponsor: **Carsten Heinz** · enrollment: 12 (actual)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** everolimus

## Key facts

- **NCT ID:** NCT00803816
- **Lead sponsor:** Carsten Heinz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-09
- **Final completion:** 2010-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00803816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00803816, "Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00803816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*